Commercialization
NeuraMetrix Can Detect and Monitor Brain Diseases Through Typing Cadence
Doctors and scientists have long struggled to detect and monitor neurodegenerative diseases such as ...
PM360’s Investor Portfolio: Andrew Burns
PM360 introduces you to the people who invest in and help startups succeed, in ...
Avoid “Merger Mayhem” When Launching Acquired Therapies
To fill gaps in product lines or move quicker to market, Big Pharma companies ...
Quench Medical is Revolutionizing Respiratory Drug Delivery
Even though intravenous chemotherapy drugs are a standard of care for lung cancer, the ...
Protecting Both Patients and Pharma
In February, serialization of pharmaceutical products became mandatory across the European Union. Contract Manufacturing ...
Improving Clinical Trial Awareness and Recruitment
The first person to be cured of pancreatic cancer—or the first Alzheimer’s survivor—will likely ...
The Promise of Emerging Digital Rx Treatments
Digital Rx treatments offer advantages for patients, not the least of which is in ...
5 Tips for Advertising Clinical Trials to Patients
Successful clinical trial advertising captures patients’ attention and inspires them to get involved, all ...
Improving Drug Development with Innovation: Barriers & Enablers Impacting Adoption
In my last article, I discussed a new report, titled The Innovation Imperative: The ...
Inside the Gray Space of Digital Therapeutics
I recently attended the second DTxDM conference of the year, which was held on ...
Changing Roles in Pharma & Biotech Companies: CSMs Are the New CRAs
The rapidly evolving clinical trial paradigm is prompting altered expectations of the traditional Clinical ...
Trials.ai is Accelerating Clinical Trials
Patients often don’t have time to wait. But, the clinical trial process can be ...
Maximizing the Probability of Trial Success for CAR-T Cell Therapies
CAR-T cells are complex products, and translating them from basic and preclinical research to ...
- 1
- 2